All In Biotech

Drug Trial Radar · NCT06817265

Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy

Phase III Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy(With Syndrome of Yin Deficiency With Internal Heat and Blood Stasis Obstructing the Collaterals of the Eyes)

Last checked: Nov 20, 2026Latest source record: Aug 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

360

Planned (sponsor's estimate)

Start

Apr 29, 2025

Primary completion

Aug 30, 2026

Study completion Dec 31, 2026

Sponsor

Sponsor type
Industry
First posted
Feb 10, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if drug TNTL works to treat non-proliferative diabetic retinopathy in adults. It will also learn about the safety of drug TNTL. The main questions it aims to answer are: 1. Does drug TNTL can improve visual acuity and reduce the degree of retinopathy? 2. What medical problems do participants have when taking drug TNTL? Researchers will compare drug TNTL to a placebo (a look-alike substance that contains no drug) to see if drug TNTL works to treat non-proliferative diabetic retinopathy. Participants will: 1. Take drug TNTL or a placebo every day for 6 months 2. Visit the clinic once every 4 weeks for checkups and tests 3. Keep a diary of their symptoms and Change from baseline

Conditions

  • Non-Proliferative Diabetic Retinopathy

Interventions

  • TNTLDrug

    oral, 4 tablets, 3 times a day, after meals. Take it for 24 weeks.

  • TNTL simulation preparationDrug

    oral, 4 tablets, 3 times a day, after meals. Take it for 24 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in best corrected visual acuity (BCVA) from baseline after 24 weeks of medication;Time frame: From enrollment to the end of treatment at 24 weeks

Locations

30 sites in 1 country. Site status is shown where the registry gives one.

  • Xuancheng People's Hospital

    Xuancheng, Anhui, China · Recruiting

  • Beijing Chaoyang Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine

    Guangzhou, Guangdong, China · Recruiting

  • Shenzhen Eye Hospital

    Shenzhen, Guangdong, China · Recruiting

  • Zhuhai People's Hospital

    Zhuhai, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

    Guiyang, Guizhou, China · Recruiting

  • Guizhou Provincial People's Hospital

    Guiyang, Guizhou, China · Recruiting

  • Shijiazhuang People's Hospital

    Shijiazhuang, Hebei, China · Recruiting

  • Kaifeng Central Hospital

    Kaifeng, Henan, China · Recruiting

  • Luoyang Third People's Hospital

    Luoyang, Henan, China · Recruiting

  • Xinxiang Central Hospital

    Xinxiang, Henan, China · Recruiting

  • People's Hospital of Zhengzhou

    Zhengzhou, Henan, China · Recruiting

  • Zhengzhou Second Hospital

    Zhengzhou, Henan, China · Recruiting

  • Taihe Hospital (Affiliated Hospital Of Hubei University Of Medicine)

    Shiyan, Hubei, China · Recruiting

  • Wuhan Puren Hospital

    Wuhan, Hubei, China · Recruiting

  • Yichang Central People's Hospital

    Yichang, Hubei, China · Recruiting

  • The First Affiliated Hospital Of University Of South China

    Hengyang, Hunan, China · Recruiting

  • Wuxi People's Hospital

    Wuxi, Jiangsu, China · Recruiting

  • Affiliated Zhongshan Hospital Dalian University

    Dalian, Liaoning, China · Recruiting

  • Shandong University of Traditional Chinese Medicine Affiliated Eye Hospital

    Jinan, Shandong, China · Recruiting

  • Shandong University of Traditional Chinese Medicine Affiliated Hospital

    Jinan, Shandong, China · Recruiting

  • Shandong Provincial Hospital

    Jinan, Shandong, China · Recruiting

  • Shandong Second Provincial General Hospital

    Jinan, Shandong, China · Recruiting

  • Liaocheng People's Hospital

    Liaocheng, Shandong, China · Recruiting

  • Xian No.1 Hospital

    Xi’an, Shanxi, China · Recruiting

  • The First Affiliated Hospital of Xi'an Medical University

    Xi’an, Shanxi, China · Recruiting

  • The First People'S Hospitalof Xian Yang

    Xianyang, Shanxi, China · Recruiting

  • The Affiliated Hospital of Southwest Medical University

    Luzhou, Sichuang, China · Recruiting

  • Panzhihua Integrated Traditional Chinese and Western Medicine Hospital

    Panzhihua, Sichuang, China · Recruiting

  • Yunnan University Affiliated Hospital

    Kunming, Yunnan, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.